Literature DB >> 31040037

Exome sequencing detects compound heterozygous nonsense LAMA2 mutations in two siblings with atypical phenotype and nearly normal brain MRI.

Simona Saredi1, Sara Gibertini1, Leslie Matalonga2, Laura Farina3, Anna Ardissone4, Isabella Moroni4, Marina Mora5.   

Abstract

LAMA2 mutations cause the most frequent congenital muscular dystrophy subtype MDC1A and a variety of milder phenotypes, characterized by total or partial laminin-α2 deficiency. In both severe and milder cases brain MRI invariably shows abnormal white matter signal intensity. We report clinical, histopathological, imaging and genetic data on two siblings with very subtle, and at first undetected, reduction in laminin-α2 expression, and brain MRI showing minor non-specific abnormalities. Clinical features in the female proband were characterized by muscle weakness involving neck and axial muscles, and pelvic girdle and distal lower limb muscles, reduced tendon reflexes and pes cavus. Clinical features in a younger brother were similar, and remained stable in both siblings during the follow up. Whole exome sequencing (WES) detected two heterozygous truncating LAMA2 mutations. Brain MRI in combination with laminin-α2 immunohistochemistry might not be sufficient and WES might be the only means to reach a diagnosis.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Congenital muscular dystrophy type 1A; LAMA2; Laminin-α2; WES

Mesh:

Substances:

Year:  2019        PMID: 31040037     DOI: 10.1016/j.nmd.2019.04.001

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  2 in total

1.  Identification of a novel LAMA2 c.2217G > A, p.(Trp739*) mutation in a Moroccan patient with congenital muscular dystrophy: a case report.

Authors:  Youssef El Kadiri; Ilham Ratbi; Fatima Zahra Laarabi; Yamna Kriouile; Abdelaziz Sefiani; Jaber Lyahyai
Journal:  BMC Med Genomics       Date:  2021-04-21       Impact factor: 3.063

2.  The RD-Connect Genome-Phenome Analysis Platform: Accelerating diagnosis, research, and gene discovery for rare diseases.

Authors:  Steven Laurie; Davide Piscia; Leslie Matalonga; Alberto Corvó; Marcos Fernández-Callejo; Carles Garcia-Linares; Carles Hernandez-Ferrer; Cristina Luengo; Inés Martínez; Anastasios Papakonstantinou; Daniel Picó-Amador; Joan Protasio; Rachel Thompson; Raul Tonda; Mònica Bayés; Gemma Bullich; Jordi Camps-Puchadas; Ida Paramonov; Jean-Rémi Trotta; Angel Alonso; Marcella Attimonelli; Christophe Béroud; Virginie Bros-Facer; Orion J Buske; Andrés Cañada-Pallarés; José M Fernández; Mats G Hansson; Rita Horvath; Julius O B Jacobsen; Rajaram Kaliyaperumal; Séverine Lair-Préterre; Luana Licata; Pedro Lopes; Estrella López-Martín; Deborah Mascalzoni; Lucia Monaco; Luis A Pérez-Jurado; Manuel Posada de la Paz; Jordi Rambla; Ana Rath; Olaf Riess; Peter N Robinson; David Salgado; Damian Smedley; Dylan Spalding; Peter A C 't Hoen; Ana Töpf; Irina Zaharieva; Holm Graessner; Ivo G Gut; Hanns Lochmüller; Sergi Beltran
Journal:  Hum Mutat       Date:  2022-06       Impact factor: 4.700

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.